A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies
Ossium Health, Inc.
Ossium Health, Inc.
City of Hope Medical Center
Incyte Corporation
Constellation Pharmaceuticals
National Institutes of Health Clinical Center (CC)
Vor Biopharma
Thomas Jefferson University
M.D. Anderson Cancer Center
Ono Pharmaceutical Co. Ltd
Cyclacel Pharmaceuticals, Inc.
Bellicum Pharmaceuticals
Chongqing Precision Biotech Co., Ltd
University of Nebraska
Canadian Cancer Trials Group
Memorial Sloan Kettering Cancer Center
Bellicum Pharmaceuticals
Takeda
Maxinovel Pty., Ltd.
M.D. Anderson Cancer Center
Novartis
M.D. Anderson Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Regimmune Corporation
M.D. Anderson Cancer Center
Incyte Corporation
University of Texas Southwestern Medical Center
National Institutes of Health Clinical Center (CC)
Viron Therapeutics Inc
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Case Comprehensive Cancer Center
National Institutes of Health Clinical Center (CC)
Stanford University
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
University of Michigan Rogel Cancer Center
OHSU Knight Cancer Institute
Prism Pharma Co., Ltd.
UNC Lineberger Comprehensive Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Cellerant Therapeutics
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Humanigen, Inc.
Fred Hutchinson Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Targazyme, Inc.
National Cancer Institute (NCI)
National Cancer Institute (NCI)